Latest filing published 30 Dec 2025 for Enveric Biosciences, Inc..
George A. Kegler discloses dealings in 2 companies, chiefly Enveric Biosciences, Inc. and Mallinckrodt plc. Over a trading history stretching from 3 January 2019 to 23 December 2025, the count stands at 6 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 30 December 2025, reports a share grant in Enveric Biosciences, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations